bioRxivImmunology
B cells expressing authentic naive human VRC01-class BCRs can be primed and recruited to germinal centers in multiple independent mouse models
D. Huang, R. K. Abbott, C. Havenar-Daughton, P. Skog, R. Al-Kolla, B. Groschel, T. Blane, S. Menis, J. T. Tran, T. C. Thinnes, S. A. Volpi, M. Pintea, J. E. Voss, N. Phelps, R. Tingle, A. R. Rodriguez, G. S. Martin, S. Kupryianov, W. R. Schief, D. Nemazee, S. Crotty
Abstract
Animal models of human antigen-specific B cell receptors (BCR) generally depend on "inferred germline" sequences, and thus their relationship to authentic naive human B cell BCR sequences and affinities is unclear. Here, BCR sequences from authentic naive human VRC01-class B cells from healthy human donors were selected for the generation of three new BCR knock-in mice. The BCRs span the physiological range of affinities found in humans, and use three different light chains (VK3-20, VK1-5, and VK1-33) found among subclasses of naive human VRC01-class B cells and HIV broadly neutralizing antibodies (bnAbs). The germline-targeting HIV immunogen eOD-GT8 60mer is currently in clinical trial as a candidate bnAb vaccine priming immunogen. To attempt to model human immune responses to the eOD-GT8 60mer, we tested each authentic naive human VRC01-class BCR mouse model under rare human physiological B cell precursor frequency conditions. B cells with high (HuGL18HL) or medium (HuGL17HL) affinity BCRs were primed, recruited to germinal centers, accrued substantial somatic hypermutation, and formed memory B cells. Precursor frequency and affinity interdependently influenced responses. Taken together, these experiments utilizing authentic naive human VRC01-class BCRs validate a central tenet of germline-targeting vaccine design and extend the overall concept of the reverse vaccinology approach to vaccine development.
- organism: human
- organism: mouse
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Diverse competitor B cell responses to a germline-targeting priming immunogen in human Ig loci transgenic mice
T. Schiffner, A. Palser, … W. R. Schief·bioRxiv·Jan 22, 2024
- Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naive human B cells
- Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial
Xiaohe Lin, Christopher A. Cottrell, … Ian A. Wilson·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 11, 2025
- Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans
Tom G. Caniels, Madhu S. Prabhakaran, … Rogier W. Sanders·bioRxiv·Oct 26, 2026
- Humanized V(D)J-rearranging and TdT-expressing Mouse Vaccine Models with Physiological HIV-1 Broadly Neutralizing Antibody Precursors
S. Luo, C. Jing, … F. W. Alt·Proceedings of the National Academy of SciencesPeer-reviewed·Dec 27, 2022
- Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen binding affinity
P. Dosenovic, E. E. Kara, … M. C. Nussenzweig·bioRxiv·Mar 2, 2018